Original assessment ยท live

TMO: Sell

Published 16 Sep 2026, 16:45 BST. This is the frozen version, not the current recommendation.

Target$178.73
Target date2027-09-11
Price known at publication$609.822026-09-11

Why this assessment was issued

Stored financial statements changed; the revised figures need checking. The model version changed. The published model version has been replaced. Record the new calculation basis even if the rating is unchanged. The central target is 70.7% below the price, meeting the 25% downside requirement. That decline also exceeds or matches the stronger-case upside of 0.0%. This is a valuation view, not a finding that the business is poor.

The central target is 70.7% below the price, meeting the 25% downside requirement. That decline also exceeds or matches the stronger-case upside of 0.0%. This is a valuation view, not a finding that the business is poor.

Supporting evidence

Year-to-date profit has improved

Across 2 completed quarters since 2025-12-31, net income was 3,387.0m versus 3,124.0m in the matching prior-year periods (USD). Check whether the latest quarter changes that direction.

The stock is leading its sector

Over one year, the stock changed +27.2% against +19.7% for Healthcare (XLV). The gap is +7.5 percentage points. These are price returns, before dividends.

Opposing evidence

Price has outpaced earnings

Over 1 year (2025-09-12 to 2026-09-11), price changed +27.2% and trailing EPS changed +8.9%. A wider gap changes the earnings multiple; it does not establish fair value.

The starting valuation is below the price

The central assumptions give $109.78 per share, -82.0% against the weekly close. This is a scenario to test, not an analyst price target.

The original scenarios

ScenarioSales growthProfit marginModel value
Weaker1.7%15.7%$107.54
Central6.7%17.5%$178.73
Stronger11.7%19.2%$272.69

Method: Cash flow across the cycle. Loss periods, gaps or differences in the earnings basis make P/E less useful here. This assessment uses operating profit, capital spending and the balance sheet instead. Loss years remain in the margin history. The earnings method could not pass its required checks; the cash-flow method passed its own input checks. These scenarios are not probability intervals.

Original assumptions and checks
tax25
price609.82
years1.1991786447638604
claims128000000.0
growth6.690504681798426
margin17.580283149171272
profit6967000000.0
shares369747286.0
cash_okTrue
debt_okFalse
growths[4.94432911870164, 7.1961386573058395, 6.184870706291012, 10.492860432980189]
revenue46336000000.0
discount8.370252172917809
downside82.36451293693612
interest1467000000.0
leverage3.4850998273508047
net_debt38485000000.0
terminal2
free_cash7318000000.0
ppe_ratio0.23210894337016574
buy_hurdle22.196260684071515
extra_debt0
volatility34.39252136814303
basis_notes[]
capex_ratio0.03658062845303867
cash_profit6967000000.0
share_ratioNot available
annual_years5
capital_cost{'tax': 25.0, 'beta': 0.7226451397068764, 'debt': 42549000000.0, 'beta_end': '2026-09-11', 'discount': 8.370252172917809, 'debt_cost': 6.46, 'risk_free': 4.96, 'beta_start': '2023-09-22', 'beta_weeks': 156, 'source_url': 'https://home.treasury.gov/resource-center/data-chart-center/interest-rates', 'debt_weight': 15.87481679944022, 'equity_cost': 9.03548379902292, 'equity_value': 225479289948.52002, 'adjusted_beta': 0.8150967598045842, 'credit_spread': 1.5, 'equity_premium': 5.0, 'risk_free_date': '2026-09-11', 'observed_interest': 3.4477896072763166}
depreciation6.3492748618784525
normal_capex6.3492748618784525
tax_measuredFalse
current_capex3.6580628453038675
working_ratio0.1640193370165746
financial_date2026-06-30
interest_cover5.521966795857734
operating_cash9013000000.0
terminal_share79.60970540404055
reporting_basisquarterly
uncapped_growth6.690504681798426
projected_margin17.48257357027645
capital_inventory{'date': '2026-06-30', 'values': {'physical_ppe': 10755000000.0, 'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0, 'total_current_assets': 23365000000.0, 'short_term_investments': 0.0, 'total_current_liabilities': 15069000000.0, 'net_deferred_tax_liability': 1579000000.0}, 'version': 'capital-scope-3', 'currency': 'USD', 'evidence': {'physical_ppe': [{'end': '2026-06-27', 'tag': 'PropertyPlantAndEquipmentNet', 'unit': 'USD', 'filed': '2026-07-31', 'value': 10755000000.0, 'accession': '0000097745-26-000144', 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/0000097745-26-000144-index.html', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}}], 'total_assets': [{'end': '2026-06-27', 'tag': 'Assets', 'date': '2026-06-27', 'unit': 'USD', 'field': 'total_assets', 'filed': '2026-07-31', 'scope': 'consolidated statement', 'start': None, 'value': 113174000000.0, 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}, 'statement_table': 5, 'statement_verified': True}], 'total_equity': [{'end': '2026-06-27', 'tag': 'StockholdersEquity', 'date': '2026-06-27', 'unit': 'USD', 'field': 'total_equity', 'filed': '2026-07-31', 'scope': 'consolidated statement', 'start': None, 'value': 52679000000.0, 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}, 'statement_table': 5, 'statement_verified': True}], 'cash_and_equivalents': [{'end': '2026-06-27', 'tag': 'CashAndCashEquivalentsAtCarryingValue', 'date': '2026-06-27', 'unit': 'USD', 'field': 'cash_and_equivalents', 'filed': '2026-07-31', 'scope': 'consolidated statement', 'start': None, 'value': 4064000000.0, 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}, 'statement_table': 5, 'statement_verified': True}], 'total_current_assets': [{'end': '2026-06-27', 'tag': 'AssetsCurrent', 'date': '2026-06-27', 'unit': 'USD', 'field': 'total_current_assets', 'filed': '2026-07-31', 'scope': 'consolidated statement', 'start': None, 'value': 23365000000.0, 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}, 'statement_table': 5, 'statement_verified': True}, {'end': '2026-06-30', 'unit': 'USD', 'value': 23365000000.0, 'financial_period_id': 5826508}], 'short_term_investments': [{'end': '2026-06-27', 'tag': 'ShortTermInvestments', 'date': '2026-06-27', 'unit': 'USD', 'field': 'short_term_investments', 'filed': '2026-07-31', 'scope': 'consolidated statement', 'start': None, 'value': 0.0, 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}, 'statement_table': 5, 'statement_verified': True}, {'end': '2026-06-30', 'unit': 'USD', 'value': 0.0, 'financial_period_id': 5826508}], 'total_current_liabilities': [{'end': '2026-06-27', 'tag': 'LiabilitiesCurrent', 'date': '2026-06-27', 'unit': 'USD', 'field': 'total_current_liabilities', 'filed': '2026-07-31', 'scope': 'consolidated statement', 'start': None, 'value': 15069000000.0, 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}, 'statement_table': 5, 'statement_verified': True}, {'end': '2026-06-30', 'unit': 'USD', 'value': 15069000000.0, 'financial_period_id': 5826508}], 'net_deferred_tax_liability': [{'end': '2026-06-27', 'tag': 'DeferredIncomeTaxLiabilitiesNet', 'unit': 'USD', 'filed': '2026-07-31', 'value': 1579000000.0, 'accession': '0000097745-26-000144', 'source_url': 'https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/0000097745-26-000144-index.html', 'period_match': {'basis': 'Cash, total assets and equity match the same filed balance sheet.', 'amounts': {'total_assets': 113174000000.0, 'total_equity': 52679000000.0, 'cash_and_equivalents': 4064000000.0}, 'filed_end': '2026-06-27', 'stored_end': '2026-06-30'}}]}, 'conflicts': []}
cash_profit_basisReported net profit
historical_margin17.48257357027645
year5_value_share79.60970540404055
depreciation_ratio0.06349274861878453
net_debt_at_target38485000000.0
non_operating_assets0
non_operating_profit_materialFalse

Recent price ยท Passed. Weekly close dated 2026-09-11.

Current financials ยท Passed. Statements through 2026-06-30; factor prices dated 2026-09-11.

Price risk ยท Passed. Risk uses the latest 52 weekly price changes.

Operating history ยท Passed. 5 annual results, retaining operating losses and unusually strong years.

Quarterly operating results ยท Passed. Four quarters through 2026-06-30.

Cash-flow and ownership inputs ยท Passed. Capital spending, depreciation estimate, operating capital, debt, cash and other ownership claims are recorded.

Depreciation basis ยท Passed. Four matching quarters of operating income and reported depreciation are required. An unrelated EBITDA-minus-EBIT difference is not treated as depreciation.

Matching currency ยท Passed. USD statements and share price.

Operating totals ยท Passed. Quarterly sales and operating profit agree with the trailing snapshot within 5%.

Operating discount rate ยท Passed. The operating cash-flow discount rate needs a current USD Treasury rate, at least two years of matching market returns, and dated debt and share inputs. An equity return hurdle is not used as the company's funding cost.

Continuing growth and funding cost ยท Passed. The funding cost must exceed continuing growth in every valuation scenario.

Scenario consistency ยท Passed. The weaker, central and stronger assumptions must give an ordered range. When growth costs more capital than it earns, a tailored operating review is required before publishing a target.

Target publication review ยท Passed. The model estimate is within SM's automatic publication range of one quarter to four times the current price. This is a review threshold, not evidence that the market price is correct.

Cash-flow value dependence ยท Passed. Cash flows beyond year five account for 79.6% of the absolute present value. This is within SM's 90% automatic publication limit.

Investment assets and operating capital ยท Passed. No material unvalued investment balance was identified in the available capital inventory. This does not establish that every asset has been independently appraised.

Policy sm-review-2-research ยท Model sm-assessment-14-operating-capital ยท Data d32b5be49b57.

Open current research โ†—

Evidence context